Overview
Regulatory filings made public on Thursday reveal a mix of coordinated insider buying in several smaller-cap names and concentrated sales by executives at larger companies. The disclosures cover direct purchases, acquisitions made indirectly through retirement accounts, the issuance and purchase of preferred shares by an entity controlled by company directors and officers, and planned or tax-related sales reported on SEC Form 4.
Top insider buys
Jewett Cameron Trading Co Ltd (NASDAQ:JCTC) recorded a cluster of purchases carried out by multiple ten-percent owners. AJB Investment Fund II, LP; AJB Capital, LLC; Adam James Bradley; and Melinda Hodges Bradley collectively acquired 11,009 shares on July 1, 2026, at $2.35 per share, for a total outlay of $25,871. The filings indicate that 5,000 of those shares were acquired indirectly by Melinda Bradley and held in her individual retirement account, while 6,009 shares were acquired indirectly by Adam Bradley and similarly held in his individual retirement account. Since those transactions, the stock has risen to $2.56, representing a 16% increase over the prior week. InvestingPro analysis cited in the filings notes that JCTC is trading below its Fair Value estimate and appears on the platform’s Most Undervalued list.
Big Digital Energy, Inc. (BGDE) disclosed a substantial preferred-stock purchase on June 30, 2026. An entity controlled by several key executives acquired Series D Convertible Preferred Stock totaling $16,700,000, representing 16,700 shares at $1,000 per share. The investment was made by Six Thirty AI, LLC, an entity managed and controlled by Joshua Kilgore, Cody Smith, and Phillip Stanley. Mr. Kilgore is listed as Executive Chairman and director, Mr. Smith as Chief Operating Officer and director, and Mr. Stanley as Chief Executive Officer and director. The ordinary shares of BGDE trade at $7.45 and were down 16.8% over the past week from a previous close of $8.04. InvestingPro data highlighted that BGDE is trading below its Fair Value estimate and appears on the Most Undervalued list, while the company’s balance sheet shows a debt-to-equity ratio of 6.78 and a financial health score characterized as "WEAK," with 14 additional InvestingPro tips referenced for investors.
HUDSON TECHNOLOGIES INC /NY (NASDAQ:HDSN) drew a concentrated buying program from Hartree Partners, LP, identified as a ten-percent owner. Hartree Partners acquired a total of 764,202 shares across three trading days - June 30 through July 2, 2026 - spending approximately $4,477,207. The reported purchase prices ranged between $5.6785 and $5.9683 per share. The specific breakdown shows 204,789 shares bought on June 30, 288,111 shares bought on July 1, and 271,302 shares bought on July 2.
Boundless Bio, Inc. (NASDAQ:BOLD) saw insider buying by Kevin Tang and Tang Capital Management LLC, both reported as ten-percent owners. Between June 30 and July 2, 2026, they purchased common stock totaling $268,880. The transactions involved shares bought at weighted-average prices in the $2.49 to $2.54 range. The stock trades at $2.50, near its 52-week high of $2.79, and has appreciated 137% over the past year. InvestingPro commentary included in the filings indicates that BOLD appears undervalued at current prices and that the company holds more cash than debt, despite experiencing rapid cash burn. On June 30, the reporting entities acquired 25,930 shares at a weighted-average price of $2.54, in multiple transactions with prices between $2.49 and $2.60, and also purchased an additional 100 shares on that same day at $2.50 per share.
COLUMBIA BANKING SYSTEM, INC. (NASDAQ:COLB) recorded a purchase by Aaron James Deer, Executive Vice President and Chief Strategy and Innovation Officer. Mr. Deer acquired 886 shares on June 30, 2026, via an employee stock purchase plan, at a price of $25.37 per share, for a total of $22,477. After the transaction, Mr. Deer directly holds 42,761 shares of Columbia Banking System common stock. COLB trades at $31.72 and has risen 36% over the prior year, trading close to its 52-week high of $32.72. InvestingPro analysis included in the disclosure indicates a Fair Value estimate of $35.44 for COLB, suggesting the shares remain undervalued by that metric, and the company currently offers a 4.55% dividend yield and trades at a price-to-earnings ratio of 12.5.
Top insider sells
CoreWeave, Inc. (NASDAQ:CRWV) was the subject of substantial executive selling in filings dated June 30, 2026, and surrounding dates. Michael N. Intrator, Chief Executive Officer and President, reported sales of approximately $37.7 million of Class A Common Stock via Form 4, involving 386,252 shares transacted at prices between $94.6561 and $99.5359 per share. The filings show that 78,560 shares were sold directly to satisfy tax withholding obligations related to the vesting and settlement of restricted stock units. Additional dispositions included 278,560 shares sold directly and 107,692 shares sold indirectly through Omnadora Capital LLC. A portion of the reported sales were executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on November 20, 2025. CoreWeave’s share price has since declined to $81.75, down roughly 15% over the past week and down 51% over the prior year. InvestingPro analysis cited in the filings indicates that CoreWeave operates with a significant debt load and is burning cash quickly, reporting negative free cash flow of $10.6 billion in the last twelve months.
In related filings, Brian M. Venturo, CoreWeave’s Chief Strategy Officer and a director, reported sales amounting to approximately $12.9 million across transactions on June 30 and July 1, 2026. These transactions included sales at prices ranging from $85.05 to $95.69 per share. On June 30, Mr. Venturo directly sold 65,493 shares at $95.69 per share to satisfy tax withholding obligations tied to the vesting and settlement of RSUs. The same filings indicate Mr. Venturo also acquired 126,771 shares through RSU settlement on that day, where each RSU represented the contingent right to receive one share of Class A Common Stock.
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) disclosed sales by Alan J Russell, Chief Scientific Officer, who sold 200,000 shares of common stock for approximately $7,881,401 on July 1, 2026. The shares were sold in multiple transactions at prices between $38.77 and $40.905 per share. The sales followed the exercise of stock options earlier the same day, in which Mr. Russell acquired 130,352 shares at an exercise price of $0.45 per share and another 69,648 shares at an exercise price of $0.18 per share. The filings note EWTX trades near a 52-week high of $43.93 and has gained 201% over the past year. InvestingPro commentary included with the filings states the stock appears overvalued when compared to its Fair Value estimate, placing EWTX on the Most Overvalued list and reporting a market capitalization of $4.25 billion.
Astera Labs, Inc. (NASDAQ:ALAB) filed a sale by director Stefan A. Dyckerhoff, who sold 12,499 shares on July 1, 2026, at $450.00 per share for a total of $5,624,550. The transactions were executed pursuant to a Rule 10b5-1 trading plan that Mr. Dyckerhoff adopted on December 1, 2025. The filings indicate the sale occurred after a steep run for ALAB’s stock, which has surged 359% over the past year and was trading at $406.42 as of July 2. InvestingPro analysis in the disclosures characterizes ALAB as appearing overvalued at current levels and lists it on the Most Overvalued list, while noting the stock exhibits notable volatility and referencing 20 additional InvestingPro tips available to subscribers. The reported sales included 3,505 shares held directly by Mr. Dyckerhoff, leaving him with 57,466 directly owned shares following the transaction.
Robinhood Markets, Inc. (NASDAQ:HOOD) filings referenced earlier trustee-led sales by Meyer Malka, a director, who sold a combined 1,173,808 shares of Class A Common Stock across transactions on August 27 and August 28, 2025, for roughly $121,937,352. The reports identify multiple Aphrodite Trusts and the Malka Trust as the sellers in those transactions, which took place at prices ranging from $103.00 to $104.94 per share. On August 27, a total of 80,520 shares were sold by three Aphrodite Trusts at prices between $104.00 and $104.51. On August 28, two separate sets of transactions were reported: 554,108 shares sold by the Aphrodite Trusts and the Malka Trust at prices between $103.00 and $103.995, followed by 539,180 shares sold by the Malka Trust at prices between $104.00 and $104.94. These transactions were carried out indirectly through trusts identified in the filings, including the Aphrodite EM Trust, Aphrodite MM Trust, Aphrodite SM Trust, and the Malka Kleiner Revocable Trust. Robinhood shares were trading at $112.73 according to the filings, up 16% over the prior week.
What the filings show and what they do not
The disclosed transactions provide a snapshot of actions by insiders and major holders. The purchases range from retirement-account acquisitions and ESPP participation to a substantial preferred-stock investment by an entity controlled by company directors and officers. The sales include both preplanned 10b5-1 dispositions and transactions undertaken to meet tax-withholding obligations associated with the vesting and settlement of equity awards.
It is important to note that insider purchases often are interpreted as a demonstration of confidence in a company's prospects, while insider sales may be executed for a range of personal or administrative reasons. The filings themselves do not reveal motivations beyond what is explicitly stated - for example, whether sales are intended for diversification, tax payments, or other personal financial planning - and therefore cannot by themselves be taken as definitive guidance about future company performance.
Sector implications
- Technology and cloud-infrastructure stocks are represented prominently on the sell side, with CoreWeave's executive sales notable for their size and the company's reported cash-burn profile.
- Biotech and pharmaceutical names appear on both sides: Boundless Bio recorded insider buying, while Edgewise posted large insider sales following option exercises.
- Financials and regional banking are represented by Columbia Banking System insider activity, where the purchase occurred under an ESPP and the company is shown with an InvestingPro Fair Value higher than its trading price.
- Energy and industrial-related names are present through the Big Digital Energy preferred-stock purchase and Hudson Technologies common-stock purchases by a large holder.
Monitoring and context
Tracking insider transactions can provide additional data points for investors weighing company fundamentals and valuation metrics. The filings summarized here include InvestingPro commentary on relative valuation, balance-sheet metrics such as debt-to-equity and free cash flow, and notes about financial health scores where cited. Investors seeking to use insider activity as part of their decision-making process should combine this information with other fundamental and technical indicators before drawing conclusions.
Bottom line
Thursday’s disclosures highlight a pattern of concentrated insider buying in several smaller-cap issuers and significant executive selling in larger or higher-profile technology and biotech companies. The filings provide exact counts, prices, and dates for the transactions reported, and include InvestingPro valuation and health commentary where noted. While purchases may signal confidence and sales may represent routine financial management, the filings do not by themselves reveal intent beyond the stated purposes such as tax withholding or execution under trading plans.